A primary care Symptoms Clinic for patients with medically unexplained symptoms: pilot randomised trial

Christopher Burton, David Weller, Wendy Marsden, Allison Worth, Michael Sharpe, Christopher Burton, David Weller, Wendy Marsden, Allison Worth, Michael Sharpe

Abstract

Objectives: To conduct a pilot trial of a primary care Symptoms Clinic for patients with medically unexplained symptoms and evaluate recruitment and retention, and acceptability of the intervention and to estimate potential treatment effects for a full trial.

Trial design: Randomised parallel group pilot trial.

Setting: Primary care in one locality.

Participants: Primary care database and postal questionnaire were used to identify patients with multiple specialist referrals and multiple physical symptoms unlikely to be explained by disease.

Interventions: General practitioner (GP) with special interest 'Symptoms Clinic' + usual care versus usual care alone. The Symptoms Clinic comprised one long (1 h) and three short (20 min) appointments.

Outcomes: Number of patients identified and recruited; acceptability of the intervention (items from Client Satisfaction Questionnaire and interview); Medical Outcomes Survey Short Form 12 (SF-12) physical component summary.

Randomisation: Automated blocked randomisation accessed by telephone.

Blinding: None. NUMBERS RANDOMIZED: 16 to intervention and 16 to usual care alone.

Recruitment: 72 patients, from seven GP practices, had repeated specialist referrals and a Patient Health Questionnaire (PHQ)-15 score of ≥10 indicating a high probability of medically unexplained symptoms. 15 were ineligible and 25 declined to participate. NUMBERS ANALYSED: 26 patients; two patients randomised to the intervention group were incorrectly included, three patients in the intervention group and one control did not complete outcome measures.

Outcome: Most patients randomised to the Symptoms Clinic found the intervention acceptable: eight out of 11 reported the intervention helped them to deal with their problems. The mean difference between groups in SF-12 physical component summary, adjusted for baseline, was 3.8 points (SD 6).

Harms: No observed harms.

Conclusions: Patients with multiple medically unexplained symptoms can be systematically identified in primary care; a randomised trial comparing the Symptoms Clinic with usual care is feasible and has the potential to show clinically meaningful benefit.

Trial registration: ISRCTN63083469.

Conflict of interest statement

Competing interests: None.

Figures

Figure 1
Figure 1
Flowchart for Symptoms Clinic Pilot Trial.

References

    1. Burton C. Beyond somatisation: a review of the understanding and management of medically unexplained physical symptoms (MUPS). Br J Gen Pract 2003;53:233–41
    1. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007;369:946–55
    1. Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med 1989;86:262–6
    1. McGorm K, Burton C, Weller D, et al. Patients repeatedly referred to secondary care with symptoms unexplained by organic disease: prevalence, characteristics and referral pattern. Fam Pract 2010;27:479–86
    1. Burton C, McGorm K, Weller D, et al. Depression and anxiety in patients repeatedly referred to secondary care with medically unexplained symptoms: a case control study. Psychol Med 2011;41:555–63
    1. Allen LA, Woolfolk RL, Escobar JI, et al. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 2006;166:1512–18
    1. Smith RC, Lyles JS, Gardiner JC, et al. Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med 2006;21:671–7
    1. van der Feltz-Cornelis CM, van Oppen P, Ader HJ, et al. Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychother Psychosom 2006;75:282–9
    1. Rosendal M, Olesen F, Fink P, et al. A randomized controlled trial of brief training in the assessment and treatment of somatization in primary care: effects on patient outcome. Gen Hosp Psychiatry 2007;29:364–73
    1. Morriss R, Dowrick C, Salmon P, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry 2007;191:536–42
    1. Larisch A, Schweickhardt A, Wirsching M, et al. Psychosocial interventions for somatizing patients by the general practitioner: a randomized controlled trial. J Psychosom Res 2004;57:507–14
    1. Salmon P, Peters S, Stanley I. Patients' perceptions of medical explanations for somatisation disorders: qualitative analysis. BMJ 1999;318:372–6
    1. Aiarzaguena JM, Grandes G, Gaminde I, et al. A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Psychol Med 2007;37:283–94
    1. Finset A, Mjaaland TA. The medical consultation viewed as a value chain: a neurobehavioral approach to emotion regulation in doctor-patient interaction. Patient Educ Couns 2009;74:323–30
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–66
    1. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737–44
    1. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092–7
    1. Smith RC, Korban E, Kanj M, et al. A method for rating charts to identify and classify patients with medically unexplained symptoms. Psychother Psychosom 2004;73:36–42
    1. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582–92
    1. Dimsdale J, Creed F. The proposed diagnosis of somatic symptom disorders in DSM-V to replace somatoform disorders in DSM-IV–a preliminary report. J Psychosom Res 2009;66:473–6
    1. Thabane L, Ma J, Chu R, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10:1.
    1. Hague J, Cohen A. The Neglected Majority: Developing Intermediate Mental Health Care in Primary Care. London: The Sainsbury Centre for Mental Health, 2005
    1. Burbaum C, Stresing AM, Fritzsche K, et al. Medically unexplained symptoms as a threat to patients' identity? A conversation analysis of patients' reactions to psychosomatic attributions. Patient Educ Couns 2010;79:207–17
    1. Burton C, McGorm K, Weller D, et al. The interpretation of low mood and worry by high users of secondary care with medically unexplained symptoms. BMC Fam Pract 2011;12:107.
    1. McGowan L, Luker K, Creed F, et al. How do you explain a pain that can't be seen?: the narratives of women with chronic pelvic pain and their disengagement with the diagnostic cycle. Br J Health Psychol 2007;12:261–74

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe